Inrom Building 2025: The Recovery Is Broad, but Nirlat and Capex Still Set the Pace
Inrom has already delivered a broad recovery across all four segments, but the real economic test for 2026 is whether Nirlat can return to normal margin structure and whether the heavy investment cycle starts generating returns rather than only revenue.